Showing results (1601-1610 of 1,873) with videos related to
Sort By:
Pageof 188
Hypertension (Dallas, Tex. : 1979)|November 26, 2025
Insulin Resistance and Blood Pressure Control on Cognitive OutcomesChenyu Fan, Xuan Wang, Liyuan Tao, et al.Journal of Neurointerventional Surgery|November 4, 2024
Tmax >4 s volume predicts stroke recurrence in symptomatic intracranial atherosclerotic stenosis with optimal medical treatmentYing Yu, Junchao Yu, Zhikai Hou, et al.Frontiers in Medicine|April 24, 2026
Monocyte cluster identification during the early stage of fracture healing in an ovariectomized mouse modelBo Zeng, Wei Wu, Ziyu Huang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2021
Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapyYingli Wang, Jiang Yu, Dan Li, et al.Neuroepidemiology|December 20, 2015
Prevalence, Awareness and Control of Hypertension in Patients with Transient Ischemic Attacks in ChinaYuesong Pan, Xingquan Zhao, Yong Jiang, et al.Therapeutic Advances in Neurological Disorders|March 25, 2020
Different risk factors in identical features of intracranial atherosclerosis plaques in the posterior and anterior circulation in high-resolution MRIZiqi Xu, Mingyao Li, Jinhao Lyu, et al.BMC Musculoskeletal Disorders|May 29, 2021
Changes in macrophage and inflammatory cytokine expressions during fracture healing in an ovariectomized mice modelLin Chen, Shao Cheng, Kanghui Sun, et al.Lipids in Health and Disease|July 4, 2024
Non-O blood types are associated with a greater risk of large artery atherosclerosis stroke and dysregulation of cholesterol metabolism: an observational studyLan Gou, Haowen Li, Yingyu Jiang, et al.Stroke and Vascular Neurology|June 5, 2026
Endothelial dysfunction mediates inflammation-driven poor prognosis in symptomatic intracranial atherosclerosis stenosisQiong Wu, Ruoyu Li, Jinfeng Yin, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 10, 2026
Efficacy and safety of dual antiplatelet treatment up to 72 hours after mild ischemic stroke or transient ischemic attack in patients with established cardiovascular diseaseZhang Xia, Ying Gao, Weiqi Chen, et al.Pageof 188